A case of medullary thyroid carcinoma in which the skin metastasis was concurrently present and response occurred to chemotherapy.
Medullary thyroid carcinoma accounts for 3% of all thyroid gland malignancies. It commonly metastasizes to liver, lung, and bone. It rarely metastasizes to skin, and only a few such cases have been documented. Cutaneous metastasis suggests a poor prognosis, with a mean survival of 7.5-19 months. The most effective treatment for skin metastasis is complete surgical removal of all local and regional lesions. The response to systemic chemotherapy is typically poor. We report a case of medullary thyroid carcinoma with cutaneous metastases, which responded to chemotherapy.
Choi
Won Je
WJ
Department of Internal Medicine, National Police Hospital, Seoul, Korea.
Lee
Yun Young
YY
Kim
Soyon
S
Kim
Yun Kwon
YK
Kim
Eun Sil
ES
Seo
Seung O
SO
Jo
Jae Hyun
JH
Lee
Seung Min
SM
Lee
Hyo Jin
HJ
Dtsch Med Wochenschr. 1976 Dec 10;101(50):1831-4
1001192
Cancer. 1966 Aug;19(8):1039-52
5916581
J Cutan Pathol. 1987 Aug;14(4):251-4
3305613
Cancer. 1972 May;29(5):1298-307
4336632
J Clin Pathol. 2004 Apr;57(4):435-8
15047753
J Am Acad Dermatol. 1997 Apr;36(4):531-7
9092737
Clin Exp Dermatol. 2003 Nov;28(6):666-8
14616838